Topic:











Programme Phase:



Content Format:









Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

5-ASA compounds

G Rogler

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Anti-TNF agents

F Baert

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Methotrexate

P Juillerat

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Steroids

S Vavricka

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Thiopurines

P Irving

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Ustekinumab

M Ferrante

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5; 6.6; 6.7; 6.8; 6.9; 6.10 : Educational update

Vedolizumab

J Lindsay

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.10; 6.11 : Educational update

Managing complications associated with anti-TNF therapy

S Ben-Horin

15th IBD Intensive Advanced Course

Webcast + PPT
 


Topic 6.5; 6.10 : State of the art

Maximising the bang for your buck: How to manage IBD on a minimum budget

P Irving

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 6.1; 6.2; 6.3; 6.4; 6.5 : State of the art

New algorithms for treating IBD

G Van Assche

ECCO 2015 Barcelona Congress

Webcast